17928580

Source:http://linkedlifedata.com/resource/pubmed/id/17928580

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0085584, umls-concept:C0205341, umls-concept:C0338237
pubmed:issue	13
pubmed:dateCreated	2008-3-25
pubmed:abstractText	Optimal treatment remains uncertain for patients with cognitive impairment that persists or returns after standard IV antibiotic therapy for Lyme disease.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01-NS38636
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17928580-17928578, http://linkedlifedata.com/resource/pubmed/commentcorrection/17928580-19171842, http://linkedlifedata.com/resource/pubmed/commentcorrection/17928580-19180682
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Ceftriaxone, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1526-632X
pubmed:author	pubmed-author:BrittonC BCB, pubmed-author:ChengJJ, pubmed-author:CorberaK MKM, pubmed-author:DobkinJJ, pubmed-author:DwyerEE, pubmed-author:FallonB ABA, pubmed-author:KeilpJ GJG, pubmed-author:NelsonD RDR, pubmed-author:PetkovaEE, pubmed-author:SackeimH AHA, pubmed-author:SlavovII
pubmed:issnType	Electronic
pubmed:day	25
pubmed:volume	70
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	992-1003
pubmed:dateRevised	2009-2-20
pubmed:meshHeading	pubmed-meshheading:17928580-Adolescent, pubmed-meshheading:17928580-Adult, pubmed-meshheading:17928580-Aged, pubmed-meshheading:17928580-Anti-Bacterial Agents, pubmed-meshheading:17928580-Arthralgia, pubmed-meshheading:17928580-Brain, pubmed-meshheading:17928580-Ceftriaxone, pubmed-meshheading:17928580-Cognition Disorders, pubmed-meshheading:17928580-Double-Blind Method, pubmed-meshheading:17928580-Drug Administration Schedule, pubmed-meshheading:17928580-Female, pubmed-meshheading:17928580-Humans, pubmed-meshheading:17928580-Injections, Intravenous, pubmed-meshheading:17928580-Lyme Neuroborreliosis, pubmed-meshheading:17928580-Male, pubmed-meshheading:17928580-Middle Aged, pubmed-meshheading:17928580-Neuropsychological Tests, pubmed-meshheading:17928580-Placebo Effect, pubmed-meshheading:17928580-Placebos, pubmed-meshheading:17928580-Recurrence, pubmed-meshheading:17928580-Time, pubmed-meshheading:17928580-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.
pubmed:affiliation	Columbia University, 1051 Riverside Drive, Unit 69, New York, NY 10032, USA. baf1@columbia.edu
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural